Atherosclerosis

Test Author ,

Morihiro Matsuda , Koji Hasegawa ,

Charles Amir German , Michael D Shapiro ,

Joost Daemen , Maria Natalia Tovar Forero ,

Tanush Gupta , Michael Weinreich , Mark Greenberg , et al

Alberto Lorenzatti , Peter P Toth ,

J Dopheide , J Veit , H Ramadani , et al

M Panajatovic , F Singh , U Duthaler , et al

GM Sanvee , M Panajatovic , J Bouitbir , et al

Edward T Carreras , Donna M Polk ,

Hans-Willi Breuer ,

Read time: 1h 1m 1s

Cameron T Lambert , Pratik Sandesara , Ijeoma Isiadinso , et al

Reynaria N Pitts , Robert H Eckel ,

Kerry Layne , Albert Ferro ,

Donald E Cutlip ,

Kazeen Abdullah , Anand Rohatgi ,

Yohei Sotomi , Richard A Shlofmitz , Antonio Colombo , et al

Iana Simova ,

Heather Currie , Christine Williams ,

Sven M Francque ,

Ewa Dembowski , Michael H Davidson ,

About

Substantial progress in the treatment of atherosclerotic complications – in particular in secondary prevention – has led to a significant reduction of recurrent cardiovascular events. This has been through the use of pharmacological strategies including lipid-lowering drugs such as statins, beta-blockers, angiotensin-converting ensyme inhibitors and angiotensin receptor blockers, along with the introduction of early percutaneous coronary intervention in acute coronary syndrome with consecutive application of dual antiplatelet therapy.

Articles

Statins and Insulin Resistance

GM Sanvee

,

M Panajatovic

,

J Bouitbir

,

S Krähenbühl

,

Citation:

European Cardiology Review 2020;15:e44.

DOI:

https://doi.org/10.15420/ecr.2020.15.1.PO21
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 4
  • Downloads: Downloads 0

Everything in Moderation: Investigating the U-Shaped Link Between HDL Cholesterol and Adverse Outcomes

Marc P Allard-Ratick

,

Pratik Sandesara

,

Arshed A Quyyumi

,

Laurence S Sperling

,

Citation:

US Cardiology Review 2019;13(1):49–53

DOI:

https://doi.org/10.15420/usc.2019.3.2
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 137
  • Downloads: Downloads 0
  • Citations: 4

Anticoagulation in Patients with Ischaemic Heart Disease and Peripheral Arterial Disease: Clinical Implications of COMPASS study

Josep Gradolí

,

Verónica Vidal

,

Adrian JB Brady

,

Lorenzo Facila

,

Citation:

European Cardiology Review 2018;13(2):115–8.

DOI:

https://doi.org/10.15420/ecr.2018.12.2
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 679
  • Downloads: Downloads 0
  • Citations: 6

Using Pharmacogenetic Testing or Platelet Reactivity Testing to Tailor Antiplatelet Therapy: Are Asians Different from Caucasians?

Doreen Tan Su-Yin

,

Citation:

European Cardiology Review 2018;13(2):112–4.

DOI:

https://doi.org/10.15420/ecr.2018.13.2.EO2
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 259
  • Downloads: Downloads 0
  • Citations: 8